Elevance Health (ELV)
Operator of Anthem and Wellpoint health plans plus Carelon pharmacy and care services.
Something off on this page? Send us feedback.
Sells commercial, Medicare, Medicaid and federal employee health plans, earning premiums or administrative fees, while Carelon supplies pharmacy, behavioral, care-delivery and analytics services to affiliated and external customers. Operations are concentrated in the United States and Puerto Rico and depend on government-program rules, medical costs and Blue Cross licenses.
Runs commercial, individual, Medicare, Medicaid and federal employee health plans through Health Benefits, using Anthem Blue Cross and Blue Shield, Wellpoint, MMM and Simply Healthcare brands. Premium-bearing plans assume medical-cost risk, while fee-based employer accounts pay for administration; dental, vision, stop-loss and supplemental products round out the portfolio. Operations are concentrated in the United States and Puerto Rico.
Extends the insurance platform through CarelonRx and Carelon Services. CarelonRx provides pharmacy-benefit management, specialty and home-delivery pharmacy, infusion, claims adjudication and formulary services; Carelon Services combines behavioral and physical care, value-based care and analytics for affiliated plans and outside customers. The model coordinates benefits, pharmacy and care management across a large membership base, but remains dependent on medical-cost trends, government-program rules and rates, state insurance oversight, Blue Cross and Blue Shield licenses, and a core pharmacy-services agreement with CVS Caremark.
Company facts
Target rangeAs of Sep 21, 2026
Latest analyst notes
| Date | Firm | Action | Prior | Current |
|---|---|---|---|---|
| Jul 17, 2026 | Leerink Partners | Reiterate | Rating: —Target: $364 | Target: $395 |
| Jul 16, 2026 | Bernstein | Target | Target: $482 | Target: $488 |
| Jul 16, 2026 | New Street | Target | Target: — | Target: $482 |
| Jul 16, 2026 | RBC Capital | Reiterate | Rating: —Target: $439 | Target: $424 |
| Jul 16, 2026 | Goldman Sachs | Reiterate | Rating: —Target: $343 | Target: $395 |
EPSReportedEstimate
RevenueReportedEstimate
Balance sheet, Jun 30, 2026Cash & short-term investments $37.51B · Total debt $31.04B · Total assets $126.44B · Shareholders' equity $44.88B
- Revenue
- $50.47B
- Operating income
- $2.06B
- Net income
- $1.46B
HistoryDividendAnnual yield
| Institutions | 92.80% | 201.26M shares | |
|---|---|---|---|
| 1,672 holders · as of Jun 30, 2026 | |||
| Insiders | 0.19% | 403.8K shares | |
| 21 holders · as of Sep 4, 2026 | |||
| Other | 7.01% | 15.21M shares | |
| remainder | |||
216.87M company shares as of Sep 22, 2026 · institutions as of Jun 30, 2026 · holders as of their latest filing
Top shareholders13F · 13D/G · Form 4
| Holder | Stake | Shares | Date |
|---|---|---|---|
BlackRock, Inc.Institution | 8.76% | 18.99M | as of Jun 30, 2026 |
Vanguard Capital Management LLCInstitution | 6.48% | 14.06M | as of Jun 30, 2026 |
State Street CorpInstitution | 4.81% | 10.43M | as of Jun 30, 2026 |
Wellington Management Group LLPInstitution | 4.25% | 9.21M | as of Jun 30, 2026 |
Vanguard Portfolio Management LLCInstitution | 2.87% | 6.21M | as of Jun 30, 2026 |
Insider tradesForm 4
| Date | Insider | Role | Shares | Avg price |
|---|---|---|---|---|
| Jul 17, 2026 | Gail Boudreaux | director, officer: President and CEO | +2,725 | $367.79 |
| Jul 17, 2026 | Ramiro G. Peru | director | +1,000 | $366.05 |
| Jun 12, 2026 | Ronald W. Penczek | officer: CAO & Controller | −369 | $403.16 |
| Jun 11, 2026 | Robert L. JR Dixon | director | −151 | $401.77 |
| May 19, 2026 | Ronald W. Penczek | officer: CAO & Controller | −1,531 | $403.13 |
- UnitedHealth Group
Head-to-head rival across commercial, MA, Medicaid, PBM, and health services.
- CVS Health
Competes via Aetna in MA and commercial insurance, and CVS Caremark in PBM.
- Cigna
Commercial employer insurance and PBM via Express Scripts / Evernorth.
- Humana
Medicare Advantage pure-play; CenterWell pharmacy competes with CarelonRx.
- Centene
Largest Medicaid managed-care pure-play and #1 ACA Marketplace carrier.
- Molina Healthcare
Pure-play government managed care; Medicaid and D-SNP state contracts overlap.
Compare
| Company | Price | Change | |||||
|---|---|---|---|---|---|---|---|
| Elevance Health | $403.70 | −1.37% | $88.77B | 18.2 | 14.8 | 0.4 | +0.8% |
| UnitedHealth Group | $374.58 | −0.79% | $342.88B | 24.3 | 17.6 | 0.8 | +0.4% |
| CVS Health | $87.68 | +0.09% | $111.77B | 23.2 | 10.8 | 0.3 | +7.3% |
| Cigna | $274.52 | +0.02% | $72.53B | 11.4 | 8.7 | 0.3 | +6.6% |
| Humana | $372.76 | −1.54% | $45.39B | 35.9 | 30.2 | 0.3 | +26.2% |
| Centene | $63.29 | −2.62% | $32.10B | — | 14.0 | 0.2 | +9.9% |
| Molina Healthcare | $191.58 | −3.14% | $10.33B | 1,041.1 | 27.2 | 0.2 | −4.8% |
| Median | 24.3 | 15.8 | 0.3 | +6.9% |